1. Home
  2. IART vs GPCR Comparison

IART vs GPCR Comparison

Compare IART & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IART
  • GPCR
  • Stock Information
  • Founded
  • IART 1989
  • GPCR 2016
  • Country
  • IART United States
  • GPCR United States
  • Employees
  • IART N/A
  • GPCR N/A
  • Industry
  • IART Medical/Dental Instruments
  • GPCR
  • Sector
  • IART Health Care
  • GPCR
  • Exchange
  • IART Nasdaq
  • GPCR Nasdaq
  • Market Cap
  • IART 1.2B
  • GPCR 1.2B
  • IPO Year
  • IART 1995
  • GPCR 2023
  • Fundamental
  • Price
  • IART $14.16
  • GPCR $30.60
  • Analyst Decision
  • IART Hold
  • GPCR Strong Buy
  • Analyst Count
  • IART 6
  • GPCR 8
  • Target Price
  • IART $15.40
  • GPCR $69.57
  • AVG Volume (30 Days)
  • IART 903.3K
  • GPCR 914.1K
  • Earning Date
  • IART 10-30-2025
  • GPCR 11-13-2025
  • Dividend Yield
  • IART N/A
  • GPCR N/A
  • EPS Growth
  • IART N/A
  • GPCR N/A
  • EPS
  • IART N/A
  • GPCR N/A
  • Revenue
  • IART $1,621,738,000.00
  • GPCR N/A
  • Revenue This Year
  • IART $5.74
  • GPCR N/A
  • Revenue Next Year
  • IART $4.35
  • GPCR N/A
  • P/E Ratio
  • IART N/A
  • GPCR N/A
  • Revenue Growth
  • IART 3.53
  • GPCR N/A
  • 52 Week Low
  • IART $11.06
  • GPCR $13.22
  • 52 Week High
  • IART $27.13
  • GPCR $42.57
  • Technical
  • Relative Strength Index (RSI)
  • IART 43.83
  • GPCR 65.79
  • Support Level
  • IART $15.26
  • GPCR $25.59
  • Resistance Level
  • IART $16.42
  • GPCR $27.49
  • Average True Range (ATR)
  • IART 0.71
  • GPCR 1.42
  • MACD
  • IART -0.03
  • GPCR -0.05
  • Stochastic Oscillator
  • IART 28.55
  • GPCR 91.17

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: